|
|
|
| |
General CME Text/Information
2011 American Urological Association Education & Research, Inc.
Annual Meeting Webcast |
| |
| Accreditation: The American Urological Association Educational & Research, Inc. (AUAER) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association Education & Research, Inc. designates this enduring material for a maximum of 37.75 AMA PRA Category 1 Credits®. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AUAER takes responsibility for the content, quality, and scientific integrity of this CME activity.
Overview/Statement of Need
Urologists need a thorough knowledge of the most recent developments and techniques in urology to ensure the highest standards of patient care and safety.
Learning Objectives
At the conclusion of the 2011 Annual Meeting, participants should be able to:
describe recent developments in the medical and surgical management of urology patients
identify new technologies for the treatment of urologic problems
outline the role of simulators in urologic training
analyze the potential threats to urologic practice and specify possible solutions
AUAER Disclosure Policy
As a provider accredited by the ACCME, the AUAER must ensure balance, independence, objectivity and scientific rigor in all its activities.
All persons in a position to control the content of an educational activity (i.e., activity planners and presenters) provided by the AUAER are required to disclose to the provider any relevant financial relationships they have with any commercial interest. The AUAER must determine if an individual’s commercial relationships may influence the educational content with regard to exposition or conclusion, and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from serving as planners or presenters, but rather to provide the audience with information on which they can make informed judgments about the material presented.
Off-label or Unapproved Use of Drugs or Devices: It is the policy of the AUAER to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Evidence Based Content: As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUAER to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
Method of Participation/Instructions
This CME activity consists of a Webcast of live scientific presentations (plenary session and courses), which were recorded during the 2011 AUAER Annual Meeting. To earn credit for each presentation, please view and listen to the full lecture and accompanying slide presentation, claim the credits you spent in the activity, and complete the evaluation.
Estimated Time to Complete Entire Webcast Activity: 38.0 hours
Each educational activity within this Webcast may be completed individually. The estimated time required to complete each individual portion of this educational activity is listed in the CME information at the beginning of each individual portion of this activity.
Release Date
May, 2011
Expiration Date
December, 2012
AUAER Privacy Policy
The AUAER is the sole owner of the information collected on this site. We will not sell, share, or rent this information to others in ways other than those outlined in this statement. Personal information provided by users will be used by the AUA to improve the site and provide a more personalized experience for the user, but information which identifies a specific individual will not be disclosed to others without the user's permission unless necessary to provide services which the user has requested.
AUA Confidentiality Statement Full Text: http://www.auanet.org/cme/onlineeduconf.cfm
Commercial Support Statement
The Plenary Session Webcasts are supported through an independent educational grant from Astellas Pharma.
Contact Information
For all inquiries regarding CME credit please contact:
Denise Williams, MEd
Enduring Materials Coordinator
American Urological Association
1000 Corporate Blvd.
Linthicum, MD 21090
410-689-4040
dwilliams@auanet.org
Disclaimer: The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUAER.
|
|
Planners: American Urological Association 2011 Annual Meeting Program Planning Committee
Committee Members Disclosures
Faculty Name |
Company |
Relationship |
Financial |
Amling, Christopher Lee |
Sanofi-Aventis |
Meeting Participant or Lecturer |
Yes |
Badlani, Gopal |
Allergan |
Investigator |
No |
|
Coloplast |
Scientific Study or Trial |
No |
|
Pfizer |
Investigator |
No |
Bahnson, Robert Roy |
Nothing to Disclose |
|
|
Bales, Gregory Thomas |
Nothing to Disclose |
|
|
Baskin, Laurence Seth |
Nothing to Disclose |
|
|
Bishoff, Jay Todd |
Perc Systems |
Consultant or Advisor |
Yes |
|
Pfizer |
Meeting Participant or Lecturer |
Yes |
Brandes, Steven Benjamin |
American Medical Systems (AMS) |
Consultant or Advisor |
Yes |
|
Allergan |
Scientific Study or Trial |
No |
|
Pfizer |
Meeting Participant or Lecturer |
Yes |
Campbell, Jeffrey Brian |
Nothing to Disclose |
|
|
Darras, Frank S. |
Nothing to Disclose |
|
|
Deane, Leslie A. |
Care Fusion |
Consultant or Advisor |
Yes |
|
Covidien |
Other: Proctor |
Yes |
|
Intuitive Surgical |
Other: Proctor |
Yes |
Donatucci, Craig F. |
American Medical Systems (AMS) |
Meeting Participant or Lecturer |
Yes |
|
Auxilium |
Other: Speaker |
Yes |
|
Endo Pharmaceuticals |
Consultant or Advisor |
Yes |
|
Lilly |
Speaker, Meeting Participant or Lecturer, Consultant or Advisor, Investigator |
No |
|
Pfizer |
Meeting Participant or Lecturer |
Yes |
|
Sciele |
Consultant or Adviser |
Yes |
|
Slate Pharmaceuticals |
Consultant or Adviser |
Yes |
Evans, Robert James |
Allergan |
Meeting Participant or Lecturer |
Yes |
|
Astellas |
Meeting Participant or Lecturer |
Yes |
|
Interstitial Cystitis Association |
Board Member, Officer, Trustee |
No |
|
Medtronic |
Meeting Participant or Lecturer |
Yes |
|
Ortho Women’s Health and Urology |
Consultant or Adviser |
Yes |
|
Pfizer |
Investigator |
Yes |
Flanigan, Robert C. |
National Cancer Institute |
Investigator |
No |
|
NIDDK (NIH) |
Consultant or Advisor |
Yes |
Forrest, John B. |
Nothing to Disclose |
|
|
Fulgham, Pat Fox |
Nothing to Disclose |
|
|
Gonzalez, Christopher Michael |
Aurasense |
Investment Interest |
No |
|
Coloplast |
Other: Gift for Reconstruction Fellowship Program |
Yes |
|
Wolf |
Other: Gift for International Surgical Relief Fund |
Yes |
Greenfield, Saul P. |
Nothing to Disclose |
|
|
Griebling, Tomas Lindor |
Johnson & Johnson |
Scientific Study or Trial |
Yes |
|
Medtronic |
Scientific Study or Trial, Consultant or Advisor |
Yes |
|
Pfizer |
Scientific Study or Trial, Investigator, Consultant or Advisor |
Yes |
Hayward, Simon |
Nothing to Disclose |
|
|
Herndon, C.D. Anthony |
Current Medical Literature |
Other: Clinical Editor |
Yes |
Honig, Stanton Charles |
Auxilium |
Investigator, Meeting Participant or Lecturer |
Yes |
|
Endo, Serono |
Consultant or Advisor |
Yes |
|
Sanofi |
Meeting Participant or Lecturer |
Yes |
|
Novartis |
Meeting Participant or Lecturer |
Yes |
|
Lilly/ICOS |
Meeting Participant or Lecturer |
Yes |
|
Coloplast |
Meeting Participant or Lecturer |
Yes |
|
American Medical Systems (AMS) |
Meeting Participant or Lecturer |
Yes |
|
Slate Pharmaceuticals |
Meeting Participant or Lecturer |
Yes |
Husmann, Douglas A. |
Nothing to Disclose |
|
|
Jarrard, David F. |
Nothing to Disclose |
|
|
Joseph, Jean Volny |
Nothing to Disclose |
|
|
Kaufman Jr., Ronald Paul |
Active Biotech |
Scientific Study or Trial |
Yes |
|
Amgen |
Scientific Study or Trial |
Yes |
|
Antigenics |
Investigator |
Yes |
|
Auxilium Pharmaceuticals, Inc |
Investigor |
Yes |
|
Boston Scientific |
Scientific Study or Trial |
Yes |
|
Endo Pharmaceuticals |
Investigator |
Yes |
|
Ferring Pharmaceuticals |
Investigator |
Yes |
|
Glaxo |
Scientific Study or Trial |
Yes |
|
Johnson & Johnson |
Investigator |
Yes |
|
Nymox Pharmaceutical Corp |
Investigator |
Yes |
|
Predictive Biosciences |
Investigator |
Yes |
|
Sanofi-Aventis US |
Investigor |
Yes |
|
Wilex, AG |
Scientific Study or Trial |
Yes |
Klein, Eric. A. |
Abbott Diagnostics |
Other: Research Support |
No |
|
Genomic Health |
Other: Research Support |
No |
Ko, Dicken Shiu-Chung |
Spirus Medical, Inc. |
Consultant or Advisor |
No |
Kolettis, Peter Nicholas |
Nothing to Disclose |
|
|
Krishnamurthi, Venkatesh |
Nothing to Disclose |
|
|
Lemack, Gary Evan |
Allergan |
Investigator |
No |
|
Astellas |
Meeting Participant or Lecturer |
Yes |
|
Contura |
Investigator |
Yes |
|
Novartis |
Consultant or Advisor |
Yes |
|
Pfizer |
Investment Interest, Meeting Participant or Lecturer, Consultant or Advisor |
Yes |
Lewis, Ronald W. |
Alza Pharmaceuticals |
Scientific Study or Trial |
Yes |
|
American Medical Systems (AMS) |
Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial |
Yes |
|
Bayer |
Consultant or Advisor |
Yes |
|
Bayer Pharmaceuticals |
Scientific Study or Trial |
Yes |
|
Glaxo Smith Kline |
Meeting Participant or Lecturer |
Yes |
|
Johnson & Johnson |
Consultant or Advisor |
Yes |
|
Lilly ICOS |
Scientific Study or Trial, Meeting Participant or Lecturer |
Yes |
|
Macrochem |
Scientific Study or Trial |
Yes |
|
Mentor Corporation |
Scientific Study or Trial, Meeting Participant or Lecturer |
Yes |
|
Pfizer, Inc. |
Meeting Participant or Lecturer, Consultant or Advisor, Scientific Study or Trial |
Yes |
|
TAP Pharmaceuticals |
Scientific Study or Trial, Consultant or Advisor |
Yes |
|
Vivus |
Meeting Participant or Lecturer, Scientific Study or Trial |
Yes |
Loughlin, Kevin R. |
Certus Biomedical |
Consultant or Advisor |
Yes |
|
Predictive Biosciences |
Board Member, Officer, Trustee |
Yes |
|
Sierra Molecular |
Consultant or Advisor |
Yes |
|
Tengion |
Consultant or Advisor |
Yes |
Mathe, Mary |
Nothing to Disclose |
|
|
McDougall, Elspeth Marguerita |
Endocare |
Other: Unrestricted Grant |
No |
|
Ethicon Endo-Surgery |
Other: Equip Support-MIS Educ Center @ UCI |
No |
|
Intuitive Surgical |
Other: Equip Support-MIS Educ Center @ UCI |
No |
|
Karl Storz Endoscopy America |
Other: Equip Support-MIS Educ Center @ UCI |
No |
|
METI, Inc |
Scientific Study or Trial |
No |
|
Simbionix |
Other: Equip Support-MIS Educ Center @ UCI |
No |
Messing, Edward M. |
Fujirebio |
Investigator |
No |
|
Novadaq, Inc. |
Investigator |
No |
Moldwin, Robert Miles |
Luitpold Pharmaceuticals |
Consultant or Advisor |
Yes |
|
Ortho-McNeil Pharmaceuticals |
Consultant or Advisor |
Yes |
|
Pfizer |
Investigator, Consultant or Advisor |
No (investigator)
Yes (consult) |
|
Plethora |
Investigator |
No |
|
Taris |
Consultant or Advisor |
Yes |
Nakada, Stephen Y. |
Cook Urological |
Consultant or Advisor |
Yes |
Nangia, Ajay Kumar |
Nothing to Disclose |
|
|
Nehra, Ajay |
American Medical Systems (AMS) |
Consultant or Advisor |
Yes |
|
Coloplast |
Consultant or Advisor |
Yes |
|
GlaxoSmithKline |
Consultant or Advisor |
Yes |
|
Sanofi-Aventis |
Consultant or Advisor |
Yes |
Nguyen, Hiep Thieu |
Nothing to Disclose |
|
|
Penson, David Fredrick |
Nothing to Disclose |
|
|
Pontari, Michel Arthur |
Endo Pharmaceuticals |
Consultant or Advisor |
Yes |
|
Pfizer |
Investigator |
No |
Rovner, Eric Scott |
Allergan |
Consultant or Advisor, Meeting Participant or Lecturer |
Yes |
|
Astellas |
Consultant or Advisor |
Yes |
|
Pfizer |
Consultant or Advisor, Investigator, Scientific Study or Trial |
Yes |
|
Solace |
Scientific Study or Trial |
Yes |
|
Tengion |
Consultant or Advisor |
Yes |
Russo, Paul |
Wilex, AG |
Consultant or Advisor |
Yes |
Scarpero, Harriette Miles |
American Medical Systems (AMS) |
Consultant or Advisor |
Yes |
Schlossberg, Steven M. |
Nothing to Disclose |
|
|
Singer, Jennifer Sandra |
Nothing to Disclose |
|
|
Smith, Carolyn Voncile |
Nothing to Disclose |
|
|
Tarantino, Arthur Edgar |
Nothing to Disclose |
|
|
Terris, Martha Kennedy |
Nothing to Disclose |
|
|
Wang, Zhou |
Nothing to Disclose |
|
|
Wein, Alan J. |
Allergan |
Consultant or Advisor |
Yes |
|
Astellas |
Consultant or Advisor |
Yes |
|
ENDO Pharmaceuticals |
Consultant or Advisor |
Yes |
|
Novartis |
Consultant or Advisor |
Yes |
|
Pfizer |
Consultant or Advisor |
Yes |
Wessells, Hunter |
American Medical Systems (AMS) |
Consultant or Advisor |
Yes |
|
Engineers and Doctors |
Investigator |
No |
|
Gerson Lehman Group |
Consultant or Advisor |
Yes |
Winfield, Howard |
Nothing to Disclose |
|
|
Wolf Jr., J. Stuart |
Terumo Corporation |
Consultant or Advisor |
Yes |
Zorn, Kevin C. |
American Medical Systems (AMS) |
Consultant or Advisor |
Yes |
|
Intuitive Surgical |
Consultant or Advisor |
Yes |
|
|
